We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$236B
AUM Growth
-$73.2B
Cap. Flow
+$2.01B
Cap. Flow %
0.85%
Top 10 Hldgs %
30.43%
Holding
11,601
New
1,426
Increased
3,968
Reduced
4,014
Closed
2,058

Sector Composition

Rank Sector Weight
1 Technology 2.05%
2 Consumer Discretionary 1.68%
3 Financials 1.25%
4 Communication Services 0.95%
5 Energy 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTPBW
9076
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$22K ﹤0.01%
54,422
+209
+0.4% +$120
OEPWW
9077
DELISTED
One Equity Partners Open Water I Corp. Warrant
OEPWW
$22K ﹤0.01%
200,601
+574
+0.3% +$121
ZY
9078
CALL
DELISTED
Zymergen Inc. Common Stock
ZY
$22K ﹤0.01%
17,500
-300
-2% -$503
CRBP icon
9079
Corbus Pharmaceuticals
CRBP
$190M
$21K ﹤0.01%
2,780
+638
+30% +$6.17K
GWH.WS
9080
DELISTED
ESS Tech Inc Warrant
GWH.WS
$21K ﹤0.01%
60,751
-120
-0.2% -$98
SOUNW icon
9081
SoundHound AI Warrant
SOUNW
$787M
$21K ﹤0.01%
+70,388
New +$40K
STXS icon
9082
Stereotaxis
STXS
$141M
$21K ﹤0.01%
+11,609
New +$27.8K
WGS icon
9083
GeneDx Holdings
WGS
$2.3B
$21K ﹤0.01%
494
-10,849
-96% -$736K
CVIIW
9084
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$21K ﹤0.01%
60,847
-4,140
-6% -$1.79K
PUCKW
9085
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$21K ﹤0.01%
209,189
+400
+0.2% +$90
GOEV
9086
PUT
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$21K ﹤0.01%
24
-35
-59% -$61.5K
MCOM
9087
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
$21K ﹤0.01%
+4
New +$43.3K
NH
9088
DELISTED
NantHealth, Inc
NH
$21K ﹤0.01%
+3,364
New +$31.4K
ETACW
9089
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$21K ﹤0.01%
160,309
-1,035
-0.6% -$148
CDTX
9090
DELISTED
Cidara Therapeutics
CDTX
$20K ﹤0.01%
+2,031
New +$25.1K
DRUG
9091
Bright Minds Biosciences
DRUG
$778M
$20K ﹤0.01%
4,940
HCTI icon
9092
Healthcare Triangle
HCTI
$2.53M
0
KALA icon
9093
KALA BIO
KALA
$14.5M
$20K ﹤0.01%
27
-21
-44% -$32.9K
NGD
9094
CALL
DELISTED
New Gold Inc
NGD
$20K ﹤0.01%
19,100
-23,100
-55% -$33.1K
PAVM icon
9095
PAVmed
PAVM
$33.9M
$20K ﹤0.01%
+47
New +$22.7K
VRCA icon
9096
Verrica Pharmaceuticals
VRCA
$87.3M
$20K ﹤0.01%
+1,058
New +$53.2K
TRAW icon
9097
Traws Pharma
TRAW
$8.1M
$20K ﹤0.01%
+599
New +$20.2K
RNTX
9098
Rein Therapeutics
RNTX
$69.9M
$20K ﹤0.01%
3,792
+2,049
+118% +$18.8K
DNA.WS
9099
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$20K ﹤0.01%
38,540
+6,056
+19% +$3.84K
TCON
9100
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$20K ﹤0.01%
503
-17
-3% -$658

Similar funds

Jane Street's Q2 2022 Portfolio in Review

As of Q2 2022, Jane Street held 11,601 positions worth $236B, down 24% from $309B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jane Street's Q2 2022 filing shows 1,426 new, 3,968 increased, 4,014 reduced and 2,058 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 30,902,851 shares worth $1.24B. The largest sale was Vanguard FTSE Europe ETF, an estimated $750M.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jane Street's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 30,902,851 shares worth $1.24B.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $1.24B increase.
  • Jane Street's biggest Q2 2022 reduction was Vanguard FTSE Europe ETF, cutting an estimated $750M.
  • Jane Street fully exited iShares MSCI Global Min Vol Factor ETF in Q2 2022, selling an estimated $229M.
  • Jane Street's ten largest holdings make up 30% of its $236B portfolio in Q2 2022.
  • Jane Street opened 1,426 new positions and closed 2,058 in Q2 2022.
  • Jane Street's portfolio value fell 24% quarter-over-quarter to $236B.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.